Your cells use the MPI gene to make and process sugars that must be attached to many proteins so they can work properly. If the MPI gene does not work, some proteins are not built correctly, which can lead to a rare inherited condition called MPI-CDG. People with this condition may have low blood sugar, diarrhea, poor growth, liver problems, or blood clotting changes. Unlike many other glycosylation conditions, brain development is often less affected.
What is a gene?
Genes are sections of DNA that give your cells instructions for making molecules or directing activities in the body. Some genes carry the information needed to make proteins, the parts of cells that do the work. Others mainly regulate when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a more detailed look at this topic, you can visit LearnHub.
Overview
MPIGene function
What if the gene works
The MPI gene helps cells make mannose, a sugar used to build and attach sugar chains to proteins. This supports normal protein processing and transport throughout the body.
Risk
What if the gene does not work
Variants in the MPI gene can cause MPI-CDG, which often affects the gut and liver, leading to diarrhea, low blood sugar, bleeding problems, and poor growth. Milder and more severe variants can change when symptoms begin and how they appear.
Treatment
What does that mean for your treatment
Pathogenic variants in the MPI gene are treatment relevant because many people respond to oral D-mannose, a targeted sugar supplement used in current care. Mannose can improve protein loss from the gut, low blood sugar, clotting problems, and liver findings, so it often shapes management early. Drug choices are otherwise not broadly changed by the MPI gene itself.
Conditions associated with MPI
Gene function
What if the gene works
Your cells use the MPI gene during everyday sugar handling. It helps switch one simple sugar building block into another form that cells can use for energy pathways and for making sugar attachments on proteins. Understanding how the MPI gene works in the body helps explain how cells keep many routine processes running smoothly.
It makes a protein that switches a common sugar building block into a mannose-based form and back again. This lets cells redirect sugar where it is needed for routine cell work.
Cells use this mannose-based material to build sugar chains that are attached to many proteins. These sugar attachments help proteins fold, travel to the right place, and work normally.
Inside cells, the MPI gene links everyday sugar processing with the supply of mannose for cell building. This supports a steady flow of materials for energy use and for maintaining normal cell surfaces.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including traits such as appearance, metabolism, and the way the body reacts to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MPI gene often make the enzyme fold poorly, become less stable, or lose part of its activity, which reduces mannose-6-phosphate and disrupts glycosylation (adding sugar chains to proteins). This is how MPI gene variants affect protein function at the cell level. Some variants leave partial activity, while more severe variants greatly reduce or nearly eliminate activity, and these stronger effects can be linked to earlier or more marked features of MPI-CDG.
How variants are linked to conditions
Pathogenic variants in the MPI gene cause MPI-CDG, often called congenital disorder of glycosylation type Ib. This rare inherited condition is commonly linked to liver disease, ongoing digestive symptoms such as diarrhea or protein loss from the gut, low blood sugar, and blood clotting problems. Many people with MPI-CDG do not have the learning or brain involvement seen in some other related conditions.
A variant is not necessarily a diagnosis
Genetic variants are common in the general population and are a normal part of human biology. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For MPI-related disease, risk is mainly set by the gene changes inherited from both parents. A family history of an MPI-related condition, or two parents who both carry an MPI variant, raises the chance for a child; lifestyle factors are not known to meaningfully change this genetic risk.
Inheritance of MPI variants
MPI-related disease is inherited in an autosomal recessive pattern. This means a child needs to inherit 2 disease-causing variants in the MPI gene, 1 from each parent, to have the condition. Parents who each carry 1 variant usually do not have the condition themselves, but with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with no familial variant. In practical terms, MPI gene inheritance affects sons and daughters equally, and either parent can pass the variant to a child.
What does my MPI result mean for my family?
For families with an MPI-related condition, parents are usually healthy carriers, and brothers and sisters may also be carriers or, less often, have the condition. Close relatives may want to know that this can run silently through a family because carriers often have no symptoms. The family impact depends on whether someone has one changed copy of the MPI gene or two.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the MPI gene, doctors use genetic testing on a blood sample or cheek swab. This is how MPI genetic testing works: a lab reads the gene’s DNA code and checks for spelling changes, small missing pieces, or other variants that may help clarify whether MPI is involved.
When should I consider getting a genetic test?
Consider MPI genetic testing if a child or adult has unexplained long-term diarrhea, poor growth or weight gain, low blood sugar, liver problems, or unusual blood clotting problems, especially when these run in the family. Testing can help confirm a rare inherited MPI-related condition that may improve with treatment.
A genetic result is only one part of your health story
Genetic results can be informative, but the amount they explain depends on the condition and on which kind of variant is present. Over time, many factors, including lifestyle, surroundings, age, and medical history, influence how the body functions. In some conditions, particularly those shaped by many genes, genetic information offers context instead of certainty and makes the most sense when viewed with the rest of a person’s care. In other situations, a genetic finding may give a direct answer. For areas like medication response, these results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medicines. It studies links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medications, genes influence both how strongly a drug works and how the body handles it. This information can support more informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the MPI gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so questions about symptoms, treatment, or possible side effects are best discussed with your doctor or pharmacist.
History
The history of the MPI gene is closely tied to the early study of congenital disorders of glycosylation, a group of inherited conditions recognized in the late 20th century. Initially understood only through visible traits, later recognized as tied to a specific gene, MPI-related disease stood out because it affected the liver and digestive system more than the brain. In the 1990s, researchers identified variants in the MPI gene as the cause of what became known as CDG type Ib. This was an important milestone because it helped separate MPI-related disease from other CDG types with different patterns. From these first observations, research expanded steadily, and MPI became known as one of the first inherited metabolic conditions in this group with a clearly effective treatment approach.